Cargando…

Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7

BACKGROUND: Glioma is one of the most common central nervous system malignant tumors, accounting for 45~60% of adult intracranial tumors. However, the clinical treatment of glioma is limited. It is of great significance to seek new therapeutic methods for glioma via gene therapy. METHODS: Long non-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ruijie, Li, Peng, Lv, Heli, Li, Nana, Ren, Suliang, Xu, Wentao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207674/ https://www.ncbi.nlm.nih.gov/pubmed/34134771 http://dx.doi.org/10.1186/s13287-021-02393-8

Ejemplares similares

Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7
por: Zhang, Ruijie, et al.
Publicado: (2022)

Cancer stem cells (CSCs), cervical CSCs and targeted therapies
por: Huang, Ruixia, et al.
Publicado: (2016)

Pancreatic CSCs and microenvironment
por: Ilmer, Matthias, et al.
Publicado: (2015)

The value of urinary exosomal lncRNA SNHG16 as a diagnostic biomarker for bladder cancer
por: Liu, Chengyi, et al.
Publicado: (2023)

ATLAS computing on CSCS HPC
por: Filipcic, Andrej, et al.
Publicado: (2015)

ATLAS computing on CSCS HPC
por: Hostettler, Michael Artur, et al.
Publicado: (2015)

Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p
por: Li, Hongdan, et al.
Publicado: (2018)

CSCs: regenerating optimism for osteosarcoma treatment
por: Levin, Adam S.
Publicado: (2018)

ALDH1A3 in CSCs
por: Sullivan, Kelly E., et al.
Publicado: (2017)

Eradication of CSCs: the roadmap for curing cancer
por: Romano, Simona, et al.
Publicado: (2020)

EMT, CTCs and CSCs in tumor relapse and drug-resistance
por: Mitra, Abhisek, et al.
Publicado: (2015)

CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
por: Sulaiman, Andrew, et al.
Publicado: (2019)

MiRNA-mediated EMT and CSCs in cancer chemoresistance
por: Dong, Bing, et al.
Publicado: (2021)

Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications
por: Li, Dai, et al.
Publicado: (2023)

Multiple Myeloma Side Population Cells Promote Dexamethasone Resistance of Main Population Cells through Exosome Metastasis of LncRNA SNHG16
por: Yang, Xi, et al.
Publicado: (2023)

SNHG1 Promotes Malignant Progression of Glioma by Targeting miR-140-5p and Regulating PI3K/AKT Pathway
por: Cai, Ren-Duan, et al.
Publicado: (2020)

Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells
por: Ni, Chao, et al.
Publicado: (2020)

Correlation between cancer stem cells (CSCs) and tumor-infiltrating lymphocytes (TILs): do TILs interact with CSCs in non-small cell lung cancer?
por: Ling, Min, et al.
Publicado: (2020)

Enabling ATLAS big data processing on Piz Daint at CSCS
por: Sciacca, Francesco Giovanni, et al.
Publicado: (2019)

Enabling ATLAS big data processing on Piz Daint at CSCS
por: Sciacca, Francesco Giovanni, et al.
Publicado: (2020)

Cancer stem cells (CSCs): metabolic strategies for their identification and eradication
por: De Francesco, Ernestina M., et al.
Publicado: (2018)

Resistance to drugs and cell death in cancer stem cells (CSCs)
por: Safa, Ahmad R
Publicado: (2020)

Long noncoding RNA SNHG16 regulates TLR4-mediated autophagy and NETosis formation in alveolar hemorrhage associated with systemic lupus erythematosus
por: Hsieh, Yu-Tung, et al.
Publicado: (2023)

Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma
por: Si, Jinchao, et al.
Publicado: (2021)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2018)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022)

LncRNA SNHG5 Promotes Proliferation of Glioma by Regulating miR-205-5p/ZEB2 Axis
por: Meng, Xiangrui, et al.
Publicado: (2019)

Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC
por: Huang, Yiwen, et al.
Publicado: (2021)

Work on CMS Muon Detector (CSCs) during Long Shutdown 1
por: Lapka, Marzena
Publicado: (2015)

Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
por: Renz, Bernhard W., et al.
Publicado: (2017)

Deciphering the role of microRNA 21 in cancer stem cells (CSCs)
por: Sekar, Durairaj, et al.
Publicado: (2016)

Functional interplay between long non-coding RNAs and Breast CSCs
por: Hussen, Bashdar Mahmud, et al.
Publicado: (2022)

lncRNA SNHG7 promotes cell proliferation in glioma by acting as a competing endogenous RNA and sponging miR-138-5p to regulate EZH2 expression
por: Deng, Yanyao, et al.
Publicado: (2021)

Correction to: Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC
por: Huang, Yiwen, et al.
Publicado: (2022)

ZRANB2/SNHG20/FOXK1 Axis regulates Vasculogenic mimicry formation in glioma
por: Li, Xiaozhi, et al.
Publicado: (2019)

Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy
por: Liao, Wenhao, et al.
Publicado: (2022)

Apoptotic tumor cell-derived microparticles loading Napabucasin inhibit CSCs and synergistic immune therapy
por: Jing, Boping, et al.
Publicado: (2023)

ABC transporters in CSCs membranes as a novel target for treating tumor relapse
por: Zinzi, Laura, et al.
Publicado: (2014)

Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
por: Phi, Lan Thi Hanh, et al.
Publicado: (2018)

The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis
por: Chen, Engeng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6mcf88845rptbbj5gipnj6nls4